Frovatriptan gets approvable letter

Vanguard Medica (LSE:VGD) and partner Elan (ELN) received an approvable letter from the FDA for frovatriptan, a 5HT 1B/1D agonist, for the acute treatment of migraine. Final U.S. marketing approval wi...